• No results found

T-cell lymphoma

Primary Cutaneous Gamma Delta T Cell Lymphoma: A Clinicopathological Analysis

Primary Cutaneous Gamma Delta T Cell Lymphoma: A Clinicopathological Analysis

... gamma-delta T-cell lymphoma (PCGD-TCL) is a very uncommon and extremely aggressive tumor, and is described in the newly revised World health organization for research and treatment of cancer clas- ...

5

The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type

The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type

... NK/T-cell lymphoma [7]. The downregulation of PRDM1 protein in B and T cell lymphomas may be ascribed to different ...[25,26]. T-bet and Ets-1 also regu- late the expression and ...

17

Case Report T-cell lymphoma with von Hippel-Lindau disease: a rare case report and review of literature

Case Report T-cell lymphoma with von Hippel-Lindau disease: a rare case report and review of literature

... Abstract: von Hippel-Lindau disease (VHLD) comprises a series of complicated clinical manifestations. We hereby described a unique case of co-existing T-cell lymphoma (TCL) and confirmed VHLD. The ...

7

Extranodal Natural Killer/T-cell lymphoma, nasal type: ‘midline lethal granuloma.’ A case report

Extranodal Natural Killer/T-cell lymphoma, nasal type: ‘midline lethal granuloma.’ A case report

... NK/T cell lymphoma, nasal type, is characterized by extensive local destruction of soft tissue, cartilage and bone, brought about by the aggressive angiocentric and angioinvasive nature of the tumour ...

5

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

... angioimmunoblastic T-cell lymphoma (AITL), and 1 (5 %) patient had anaplastic large cell lymphoma (ALCL) anaplas- tic lymphoma kinase (ALK) ...helper T-cell cases ...

7

Peripheral T cell lymphoma: clinical utility of romidepsin

Peripheral T cell lymphoma: clinical utility of romidepsin

... peripheral T cell lymphoma was declared to be in complete remission after the eighth cycle of ...in T cell lymphoma and warranted further investiga- tion in a Phase II ...

7

A Rare Entity of Angioimmunoblastic T Cell Lymphoma

A Rare Entity of Angioimmunoblastic T Cell Lymphoma

... Angioimmunoblastic T Cell Lymphoma (AITL) is a well-reco- gnized subtype of peripheral T cell ...stem cell transplant ...

6

BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia

<p><em>BRAF</em> V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia</p>

... This is an interesting case of concurrent HCL and MEITL sharing the same genetic and phenotypic manifestation. Importantly, the T-cell lymphoma was diagnosed later than the initial HCL, when it ...

6

Therapeutic options in peripheral T cell lymphoma

Therapeutic options in peripheral T cell lymphoma

... Peripheral T cell lymphoma (PTCL) is a rare and heterogeneous group of non-Hodgkin lymphomas with a very poor ...anaplastic lymphoma kinase (ALK)-positive anaplastic large cell ...

10

Original Article Discordant lymphoma consisting of mantle cell lymphoma and angioimmunoblastic T cell lymphoma: homology or heterogeneity?

Original Article Discordant lymphoma consisting of mantle cell lymphoma and angioimmunoblastic T cell lymphoma: homology or heterogeneity?

... and T cell lymphoma simultaneously. Also, the subtype of T cell lymphoma in these patients that was combined with MCL was peripheral T cell lymphoma, NOS ...

8

Chidamide in the treatment of peripheral T-cell lymphoma

Chidamide in the treatment of peripheral T-cell lymphoma

... Mature T-cell lymphomas are aggressive ...mature T-cell ...mature T-cell lymphomas, an overall response rate of 28% (complete remission/complete remission unconfirmed: 14%) was ...

6

Romidepsin in the treatment of cutaneous T-cell lymphoma

Romidepsin in the treatment of cutaneous T-cell lymphoma

... peripheral T-cell lymphoma was declared to be in complete remission after the eighth cycle of romidepsin, with complete disappearance of his skin lesions and diffuse ...of T-cell ...

11

T-cell lymphoma in the nasal cavity of a Brown Swiss heifer

T-cell lymphoma in the nasal cavity of a Brown Swiss heifer

... small cell lymphoma ...as T-cell lymphoma. Lymphoma caused by bovine leukaemia virus is B-cell lymphoma [22], whereas SBL is more likely to be associated with ...

5

Novel therapeutic agents for cutaneous T-Cell lymphoma

Novel therapeutic agents for cutaneous T-Cell lymphoma

... large–cell lymphoma into 6 cohorts at varying dose and schedule and established the optimal dose and schedule as 15 mg/m2 weekly for 3 out of 4 weeks based on grade 3 mucositis ...of T-cell ...

15

Original Article Intravascular cytotoxic T-cell lymphoma presenting as hydrocele testis: a case report and review of the literature

Original Article Intravascular cytotoxic T-cell lymphoma presenting as hydrocele testis: a case report and review of the literature

... The mechanism for IVL showing a predilection of intravascular growth has not be fully under- stood, some reports suggested that alteration of adhesion molecules might play a role [11]. For example, the neoplastic cells ...

7

An update on the management of peripheral T-cell lymphoma and emerging treatment options

An update on the management of peripheral T-cell lymphoma and emerging treatment options

... Treatment consisted of 6–8 cycles of CHOP or etoposide plus CHOP (CHOEP). Three-year event-free survival (EFS) and OS was 75.8% and 89.8% (ALK-positive ALCL), 50.0% and 67.5% (AITL), 45.7% and 62.1% (ALK-negative ALCL), ...

11

Angioimmunoblastic T Cell Lymphoma Mimicking Chronic Urticaria

Angioimmunoblastic T Cell Lymphoma Mimicking Chronic Urticaria

... Peripheral T cell lymphomas (PTCL) represent less than 15– 20% of all non-Hodgkin’s lymphomas in ...munoblastic T cell lymphoma (AITL) is a rare but distinct type of T ...

6

Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis

<p>Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis</p>

... Angioimmunoblastic T-cell lymphoma (AITL) and ana- plastic large cell lymphoma (ALCL) are two distinct sub- types of ...CD30-positive T-cell non-Hodgkin lymphomas that ...

12

Paediatric T-cell lymphoma of the appendix: a case report

Paediatric T-cell lymphoma of the appendix: a case report

... MALT-type lymphoma, mantle cell lymphoma and Burkitt’s lymphoma have been reported ...cytotoxic T-cell NHL. In childhood, ALK-positive anaplastic large cell ...

6

Original Article Detection of immunoglobulin and T-cell receptor gene rearrangements in angioimmunoblastic T-cell lymphoma

Original Article Detection of immunoglobulin and T-cell receptor gene rearrangements in angioimmunoblastic T-cell lymphoma

... and T-cell receptor gene rearrangements in the diagno- sis and differential diagnosis of angioimmunoblastic T-cell ...munoblastic T-cell lymphoma confirmed by ...

12

Show all 10000 documents...

Related subjects